I raised the same issue on the meaning of the word "acquired" when this was first announced.....From what I found looking around the net I find it hard to believe we got much money out of this, largely because XCHC doesnt appear to have any in the first place...I suspect that means shares...but it's all guessin' till the 8k comes out....I think I figured the next part out....
Interlocking directorship - refers to the practice of members of a corporate board of directors serving on the boards of one or more other corporations
Direct interlock - occurs when two firms share a director or when an executive of one firm sits on the board of a second firm.
Indirect interlock - occurs when two corporations have directors who each also serve on the board of a third firm.
Some theorists believe that because multiple directors often have interests in firms in different industries, they are more likely to think in terms of general corporate class interests, rather than simply the narrow interests of individual corporations.
Multiple directors tend to be more frequently appointed to government positions, and sit on more non-profit/foundation boards than other directors. Thus, these individuals (known as the "inner circle" of the corporate class) tend to contribute disproportionately to the policy-planning and government groups that represent the interests of the corporate class, and are the ones that are most likely to deal with general policy issues and handle political problems for the business class as a whole
That is the million dollar question that still remains as they are late filling an 8k
Quote
The big question is...how does this benefit CBIS if they sold Phytiva?
The other interesting question is this word "acquired" - what were the terms of this deal? Money? Shares? And lastly, three members of CBIS' board is on the Phytiva board - which begets another question, is there a financial benefit to CBIS appointing those members?